The raid was carried out by California’s newly formed Unified Enforcement Task Force, which Governor Gavin Newsom recently sanctioned to protect “communities and consumers throughout California and the U.S. from unregulated and potentially harmful cannabis products.”
Previous research has shown that cannabis use disorder (CUD) can be treated with a combination of counseling and cannabis medicines with a 1:1 ratio of CBD and THC. But men and people with sleep issues may benefit from additional support, new analysis suggests.
The study will involve 10 participants, aged between six months and 21 years, who all have severe symptoms from non-cancerous conditions, such as cerebral palsy, neurodegenerative disorders, and progressive cardiac disease.
In a notice published on October 4, the Department of Cannabis Control announced that the test will be limited to dried flower and pre-rolls.
Scientists have developed a new compound which interacts with the same therapeutic targets in the brain as psychedelic drugs, producing the same long-lasting antidepressant and antianxiety effects but without the psychedelic high.
Alberta will become the first province in Canada to regulate psychedelic-assisted therapy.
The decision marks the first major steps towards US-wide cannabis decriminalization, a policy the president promised to implement during his campaign run.
The leading US testing standards organization ASTM International has approved four new testing standards for cannabis samples.
California’s cannabis regulator will provide $20 million in funding for new cannabis-related research.